NEOMOVRA Trademark

Trademark Overview


On Friday, February 12, 2021, a trademark application was filed for NEOMOVRA with the United States Patent and Trademark Office. The USPTO has given the NEOMOVRA trademark a serial number of 79308600. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, April 2, 2024. This trademark is owned by NOVARTIS AG. The NEOMOVRA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
neomovra

General Information


Serial Number79308600
Word MarkNEOMOVRA
Filing DateFriday, February 12, 2021
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, April 2, 2024
Registration Number6473639
Registration DateTuesday, September 7, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 22, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, April 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, May 18, 2021ASSIGNED TO EXAMINER
Thursday, April 8, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, April 13, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, April 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 20, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, May 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 2, 2021NOTICE OF PUBLICATION
Tuesday, June 22, 2021PUBLISHED FOR OPPOSITION
Friday, July 9, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 9, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 9, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 7, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, October 7, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Sunday, November 28, 2021NOTIFICATION PROCESSED BY IB
Wednesday, October 30, 2024DEATH OF INTERNATIONAL REGISTRATION
Wednesday, October 30, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, November 8, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 8, 2021FINAL DISPOSITION PROCESSED